Source: Child's Nervous System. Unidades: FMRP, FFCLRP
Subjects: MEDULOBLASTOMA, METOTREXATO, RADIOTERAPIA, ÓLEOS ESSENCIAIS, ANTINEOPLÁSICOS, FARMACOTERAPIA
ABNT
SILVA, Marcela de Oliveira et al. Perillyl alcohol for pediatric TP53- and RAS-mutated SHH-medulloblastoma: an in vitro and in vivo translational pre-clinical study. Child's Nervous System, v. 37, n. 7, p. 2163-2175, 2021Tradução . . Disponível em: https://doi.org/10.1007/s00381-021-05115-w. Acesso em: 06 nov. 2024.APA
Silva, M. de O., Sousa, G. R. de, Simões, S. C., Nicolucci, P., Tamashiro, E., Saggioro, F. P., et al. (2021). Perillyl alcohol for pediatric TP53- and RAS-mutated SHH-medulloblastoma: an in vitro and in vivo translational pre-clinical study. Child's Nervous System, 37( 7), 2163-2175. doi:10.1007/s00381-021-05115-wNLM
Silva M de O, Sousa GR de, Simões SC, Nicolucci P, Tamashiro E, Saggioro FP, Oliveira RS de, Brassesco MS. Perillyl alcohol for pediatric TP53- and RAS-mutated SHH-medulloblastoma: an in vitro and in vivo translational pre-clinical study [Internet]. Child's Nervous System. 2021 ; 37( 7): 2163-2175.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00381-021-05115-wVancouver
Silva M de O, Sousa GR de, Simões SC, Nicolucci P, Tamashiro E, Saggioro FP, Oliveira RS de, Brassesco MS. Perillyl alcohol for pediatric TP53- and RAS-mutated SHH-medulloblastoma: an in vitro and in vivo translational pre-clinical study [Internet]. Child's Nervous System. 2021 ; 37( 7): 2163-2175.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s00381-021-05115-w